Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
  • EVIP - Vaccination portal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • News & events
  • Publications & data
  • Tools
  • About us
  • Search

Search

Filter by
  • Filter by
  • Remove this filter Infectious disease: Vaccine preventable diseases
  • Remove this filter Infectious disease: Influenza A (H1N1)2009
  • Remove this filter Type: News
  • Remove this filter Type: ECDC comment
  • Remove this filter Public health area: Prevention and control
  • Remove this filter Public health area: Antiviral
  • Infectious disease
    • Vaccine preventable diseases (2)
    • Influenza A (H1N1)2009 (2)
    • Respiratory diseases (2)
    • Influenza (2)
    • Influenza A (H1N1) (2)
    • Influenza in humans, seasonal (1)
    • Seasonal influenza (1)
    • Flu (1)
  • Public health area
    • Prevention and control (2)
    • Antiviral (2)
    • Surveillance (1)
    • Immunisation (1)
    • Vaccination (1)
    • Active immunisation (1)
  • Country
    • Europe (1)
  • Media type
    • News (2)
    • ECDC comment (2)
  • Page 1 of 1 // 2 Results found
    • Sort by:

News

Two evaluations of the response to the 2009 Pandemic in Spain: Surveillance and Vaccines and antiviralsArchived

ECDC comment - 27 Sep 2011

Two official evaluations have been made by the national Ministry of Health of Spain of their country’s response to the 2009 influenza pandemic. The reviews focused on two particular topics - Surveillance and Vaccines and Antivirals.

  • Antiviral
  • Immunisation
  • Influenza
  • Influenza A (H1N1)2009
  • Spain
  • Surveillance

News

How effective were neuraminidase inhibitors during the 2009 pandemic?Archived

ECDC comment - 18 Dec 2012

​This systematic review and meta-analysis of observational data from an established group of specialists assessed treatment outcomes for all three neuraminidase inhibitors (NAIs); oseltamivir, zanamivir and peramivir given to hospitalised patients with influenza A(H1N1)pdm09 during the 2009 pandemic.

  • Antiviral
  • Influenza
  • Influenza A (H1N1)2009
  • Influenza in humans, seasonal
  • About us

    • What we do
    • Who we are
    • Governance
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy data
  • Personal data protection
  • Language policy
  • Cookie policy
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2021
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
    • EVIP - Vaccination portal
  • Home
  • All topics: A to Z
  • News & events
  • Publications & data
  • Tools
  • About us